Patent & IP news for December 2, 2012

Patent Litigations

  • No new litigations this day!



Patent & IP Blogs

post image Roller Coaster Day for Myriad Genetics from

It was a bit of a roller coaster day for US biotech Myriad Genetics as it share price plunged 9% on news that the US Supreme Court would be reviewing it '782 patent directed towards ...

Share via E–mail | Twitter | Facebook

post image Fine Art: The Oddest Market of Them All? from

It's not like the market for selling a large patent portfolio for many tens of millions of dollars. Still, the market for fine art is idiosyncratic and it is like no other market. From ...

Share via E–mail | Twitter | Facebook

post image Patents Encompassing a Human Organism from

Ex Parte Kamrava (PTAB 2012), APN 10/080,177 Download 10080177 Most Section 101 subject matter eligibility problems can be cured by integrating the ineligible subject matter with subject matter that is patent eligible. This ...

Share via E–mail | Twitter | Facebook

Lame Duck Patent Reform: AIA Technical Corrections from

On Friday, November, 30, 2012, a bill making technical changes to the AIA was introduced in the House of Representatives. The bill number is HR 6621. The proposed AIA package does NOT include a so-called ...

Share via E–mail | Twitter | Facebook

If Twinkies can Survive Nuclear War, They can Survive This from

Hostess, the brilliant minds behind the TwinkieTM, filed for a motion to wind down business operations as the result of being unable to reach an agreement with the Bakery, Confectionery, Tobacco Workers and Grain Millers ...

Share via E–mail | Twitter | Facebook

Conference & CLE Calendar from

December 3-5, 2012 - Drug and Medical Device Litigation*** (American Conference Institute) - New York, NY December 4-5, 2012 - Paragraph IV Disputes*** (American Conference Institute) - San Francisco, CA December 11, 2012 - Preissuance Prior Art Submissions at the ...

Share via E–mail | Twitter | Facebook

Court Report from

By Sherri Oslick -- About Court Report: Each week we will report briefly on recently filed biotech and pharma cases. Takeda Pharmaceutical Co. et al. v. Lupin Ltd. et al. 3:12-cv-07333; filed November 29, 2012 ...

Share via E–mail | Twitter | Facebook

News from Abroad: UK IPO Stem Cell Decisions Raise Questions Concerning the Brüstle Decision from

By Jenny Donald -- Two UK applications were rejected by a UK examiner on the ground that they constituted the 'use of human embryos for industrial or commercial purposes', which is excluded from patentability. The applications ...

Share via E–mail | Twitter | Facebook

Some content © 2007–2014 RPX Corporation.
Terms of Service & Privacy Policy
For DMCA requests contact